Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > SC 23G/A Filing

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Feb 08, 2024 7:13am

112 Views

Post# 35869225

RE:RE:RE:RE:RE:SC 23G/A Filing

What would that look like a LBO of Thera. Lucky if we het 6usd or in real world 1.50usd pre giveaway. That would imply TH1902 is pretty worthless and that it's a declining cashflow exercice for the next couple of years.

<< Previous

Bullboard Posts

Next >>

Red Light Holland and PharmAla notch psilocybin extraction